Integra (IART) Short-Term Debt to Capital

Integra LifeSciences - graphic logo of issuer IART

Integra LifeSciences (IART) efficiency in neurosurgery relies on production stability and the success of new biomaterials, with margins standing at 0.04. Business reliability is bolstered by plant diversification and the control of inventory reserves. This market valuation chart demonstrates the financial condition of the specialized equipment manufacturer, which is implementing energy saving and eco-friendly packaging to comply with ESG standards.

Integra LifeSciences Corp - IART Short-Term Debt to Equity Ratio (period 07/04/2022 - 10/28/2026)

Analytical breakdowns for integralife.com (IART)

- price and consensus price forecast:
Price Chart Integra|IART - Forecast Levels Chart
- market capitalization data:
Market Capitalization Integra LifeSciences Corp|IART - Total Enterprise Value
- book capitalization data:
Book Value per Share Integra LifeSciences|IART - Company Net Assets|Market Capitalization to Book Value Ratio integralife.com|IART - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Integra LifeSciences|IART - Long-Term Debt to Capital|Short-Term Debt to Equity Integra LifeSciences Holdings Corporation|IART - Company Debts|Debts to Book Capitalization Integra LifeSciences Corp|IART - Long-Term Debt Volume|Company Current Liabilities Integra LifeSciences
Comprehensive company analysis:Integra, IART
Brand item of Integra LifeSciences Holdings Corporation

This indicator measures the share of short-term liabilities within the equity structure, allowing for the identification of hidden liquidity risks and an assessment of the business's actual debt load. The current value of 0.04 and the trend of loans with maturities of up to one year relative to equity confirm the financial stability of Integra LifeSciences (IART), ensuring the uninterrupted operation of precision robotic lines for the production of neurosurgical instrumentation.

Competitors of Integra LifeSciences

BSX - Short-Term Debt to Equity|Current Liabilities to Equity Edwards Lifesciences Inc. (EW)|RMD: Short-Term Debt to Capital|Current Liabilities to Capital insulet.com PODD|ZBH: Short-Term Debt to Capital|COO - Short-Term Debt to Equity Ratio|Align Technology Inc - Short-Term Debt to Capital|NuVasive (GMED) - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital ATEC|Short-Term Debt to Equity Artivion (AORT)|Short-Term Debt to Equity Enovis Corp (ENOV)|Short-Term Debt to Capital ESTA|BBNX - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Current Liabilities to Equity|Short-Term Debt to Capital TNDM|AxoGen Inc (AXGN) - Current Liabilities to Capital|Short-Term Debt to Capital SI-BONE Corp (SIBN)|Short-Term Debt to Capital Ratio Orthofix Corp (OFIX)|Bioventus Inc. (BVS) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital KIDS (orthopediatrics.com)|Treace Medical Concepts, Inc. - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Blade Air Mobility SRTA|CARL (Carlsmed Corp) - Short-Term Debt to Capital|RXST - Current Liabilities to Capital|Short-Term Debt to Capital clearpointneuro.com|stereotaxis.com (STXS) - Short-Term Debt to Capital Ratio|STIM: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Sight Sciences Inc.|Short-Term Debt to Capital OBIO (Orchestra BioMed)|Short-Term Debt to Equity Ratio anikatherapeutics.com (ANIK)|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Short-Term Debt to Capital|VANI - Short-Term Debt to Equity|Xtant Medical Holdings (XTNT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital MYO (Myomo, Inc.)|Current Liabilities to Capital COCH|VVOS: Short-Term Debt to Equity|Short-Term Indebtedness to Equity enVVeno Medical Corporation NVNO|Short-Term Debt to Equity Ratio SINT (Sintx Technologies, Inc.)|Short-Term Debt to Capital Tenon Medical Inc TNON|Short-Term Debt to Capital LFWD (ReWalk Robotics Ltd.)|AMIX: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity INVO Fertility (IVF)|BBLG (Bone Biologics Corp.) - Current Liabilities to Equity|Short-Term Debt to Equity AXNX|Short-Term Debt to Equity Ratio Biolase Inc.|Dynatronics Corporation - Short-Term Debt to Capital|Current Liabilities to Capital FNA (paragon28.com)|INVO - Short-Term Debt to Equity